Trials / Completed
CompletedNCT04580290
Jewel ACL Post Market Clinical Follow Up Study
The JewelACL Post Market Clinical Follow Up Study - Multicentre Study of at Least 5 Years Follow up, Looking at Clinical Outcomes in Patients Treated With the JewelACL for Anterior Cruciate Ligament (ACL) Reconstruction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Xiros Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to assess re-rupture rates and patient outcomes from subjects with at least 5 year follow up, treated with the JewelACL device for ACL reconstruction. The impact of fixation type and autograft augmentation will also be assessed. All adverse events related to the JewelACL device will be recorded. This study is Sponsored by Xiros.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | JewelACL | The JewelACL is a polyester scaffold for anterior cruciate ligament (ACL) reconstruction |
Timeline
- Start date
- 2020-10-02
- Primary completion
- 2021-04-09
- Completion
- 2021-04-09
- First posted
- 2020-10-08
- Last updated
- 2021-11-02
- Results posted
- 2021-11-02
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT04580290. Inclusion in this directory is not an endorsement.